Advanced search
Publication Cover
British Journal of Biomedical Science Volume 75, 2018 - Issue 2
Journal homepage
255
Views
2
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Prognostic value of serum levels of soluble MICA (sMICA) in patients with prostate cancer

Y LiuDepartment of Urology, Qilu Hospital of Shandong University, Jinan, China;Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
,
X GuoDepartment of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
,
M XingDepartment of Urology, Qilu Hospital of Shandong University, Jinan, China;Department of Clinical Laboratory, Yuhuangding Hospital of Yantai, Yantai, China
,
K ZhaoDepartment of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China
,
L LuoDepartment of Urology, The Affiliated Hospital of Qingdao University, Qingdao, ChinaCorrespondence[email protected]
&
J DuDepartment of Urology, Qilu Hospital of Shandong University, Jinan, China;Department of Clinical Laboratory, Yuhuangding Hospital of Yantai, Yantai, China
Pages 98-100 | Received 12 Oct 2017, Accepted 03 Nov 2017, Published online: 07 Mar 2018

References

  • Prensner JR, Rubin MA, Wei JT, et al. Beyond PSA: the next generation of prostate cancer biomarkers. Sci Trans Med. 2012;4:127rv3.
  • Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Nat Cancer Inst. 2009;101:1325–1329.10.1093/jnci/djp278
  • Groh V, Wu J, Yee C, et al. Tumor-derived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature. 2002;419:734–738.10.1038/nature01112
  • Waldhauer I, Goehlsdorf D, Gieseke F, et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 2008;68:6368–6376.10.1158/0008-5472.CAN-07-6768
  • Ashiru O, Boutet P, Fernandez-Messina L, et al. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 2010;70:481–489.10.1158/0008-5472.CAN-09-1688
  • Pende D, Rivera P, Marcenaro S, et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002;62:6178–6186.
  • Jinushi M, Takehara T, Tatsumi T. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol. 2005;43:1013–1020.10.1016/j.jhep.2005.05.026
  • Groh V, Wu J, Yee C. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature. 2002;419:734–738.10.1038/nature01112
  • Holdenrieder S, Stieber P, Peterfi A, et al. Soluble MICA in malignant diseases. Int J Cancer. 2006;118:684–687.10.1002/ijc.21382
  • Xiao P, Xue L, Che LH, et al. Expression of membrane/soluble MHC class I chain-related molecule A and NKG2D receptor in osteosarcoma and its clinical significance. Zhonghua Bing Li Xue Za Zhi. 2007;36:596–599.
  • Rebmann V, Schütt P, Brandhorst D, et al. Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients. Clin Immunol. 2007;123:114–120.10.1016/j.clim.2006.11.007
  • Soloway MS, Hardeman SW, Hickey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195–202.10.1002/(ISSN)1097-0142
  • Raffaghello L, Prigione I, Airoldi I. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia. 2004;6:558–568.10.1593/neo.04316
  • Chen J, Xu H, Zhu XX. Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer. Ther Clin Risk Manag. 2015 Dec;22(12):11–8.
  • Li JJ, Pan K, Gu MF, et al. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma. Chin J Cancer. 2013 Mar;32(3):141–148.10.5732/cjc.012.10025

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.